Skip to main content

Table 4 Clinicopathological characteristics of patients with low risk

From: Influence of adjuvant chemotherapy on survival for patients with completely resected high-risk stage IB NSCLC

 

ACT group (n = 20)

observation group (n = 82)

P value

Age

60.90 ± 12.42197

6 ± 9.42682

0.806

Gender

  

0.036*

Male

1(5%)

22(26.82%)

 

Female

19(95%)

60(73.17%)

 

Histology

   

Adenocarcinoma

18(90%)

77(93.90%)

 

LEP

2(10%)

5(6.09%)

 

ACI-PAP

16(80%)

72(87.80%)

 

MIP-SOL

0(0%)

0(0%)

 

Squamous cell carcinoma

2(10%)

2(2.43%)

 

Poor differentiated

0(0%)

0(0%)

 

Moderate-high differentiated

2(10%)

2(2.43%)

 

Mixed

0(0%)

3(3.65%)

 

Number of resected lymph nodes

21.23 ± 5.224

22.59 ± 8.779

0.623

Tumor diameter(mm)

32.20 ± 2.52566

30.87 ± 2.76839

0.572

Vascular invasion

  

0.996

Yes

0(0%)

2(2.43%)

 

No

20(100%)

80(97.56%)

 

Visceral pleural invasion

  

0.984

Yes

8(40%)

33(40.24%)

 

No

12(60%)

49(59.75%)

 

Recurrence

  

0.543

Yes

1(5%)

2(2.43%)

 

No

19(95%)

80(97.56%)

 

Death

  

0.543

Yes

1(5%)

2(2.43%)

 

No

19(95%)

80(97.56%)

Â